Haematology Dashboard

2026-27 Re-Registration

UK NEQAS Haematology:

Re-Registration is now open and the main contact will be emailed to invite them to renew their services.  The email will include instructions on what they need to do to renew the services for the period 1 April 2026 to 31 March 2027.  Online re-registration is not required if you are a participant registered via an agent.  As part of the online Re-Registration process, the main contact will also be able to update any contact details. 

2026/27 PDF copies of exercise schedules have been uploaded and can be accessed in the documents section. You can also use our online schedules list by clicking here Online schedules.

Upon completion of Re-Registration process, the main contact will receive an email confirmation which will include the quote.

For queries please contact [email protected]

UK NEQAS Blood Transfusion Laboratory Practice (BTLP):

Re-registration for all BTLP schemes including Pre-Transfusion Testing (PTT), FMH, ABO Titration, DAT, Extended Red Cell Phenotyping (ERP), Red Cell Genotyping (RCG) and Antenatal Titration (ANT) schemes will open towards the end of February 2026.  You will receive an email once the re-registration process opens with instructions on what you need to do to renew membership for the period 1 April 2026 to 31 March 2027.   Online re-registration is not required if you are a participant registering via an agent.

2026/27 PDF copies of exercise schedules have been uploaded and can be accessed in the documents section. You can also use our online schedules list by clicking here Online schedules.

2026/27 Newsletters now available

Click on the links below to read all the latest news and updates from our two teams, just in time for re-registration:

UK NEQAS Haematology 2026/27 Newsletter
UK NEQAS BTLP 2026/27 Newsletter

Dr John Parker-Williams

In Memory of Dr John Parker-Williams

UK NEQAS Haematology wishes to acknowledge the passing of Dr John Parker-Williams. John (affectionately known as JPW by many friends and colleagues) was a former Scheme Director and later a valued member of the Morphology Scientific Advisory Group. He was a major contributor and steadfast supporter of UK NEQAS Haematology for many years.

John was deeply dedicated to the field of haematology and passionate about quality assurance. UK NEQAS Haematology would not be where it is today without his commitment and influence.

To honour John’s memory, donations and messages of condolence can be shared through the Royal Trinity Hospice tribute page:

https://www.royaltrinityhospice.london/InMemoryOf/johnparkerwilliams

Pause in QAPC and NQAAP activity from January 2026

UK NEQAS Haematology and Transfusion regrets the pause in activity of the QAPC and NQAAP oversight of laboratory performance from January 1st, 2026, as notified by the RCPath, IBMS and LabMed.  UK NEQAS supports the need for an independent system of review of both laboratory and method-related performance within the UK.

We will continue to manage performance concerns internally after January 1st 2026.  In the case of persistent unsatisfactory or poor performance of either testing sites or methods, we will work with the support of the Steering Committee, other UK NEQAS centres, commercial companies and/or the MHRA, as required, to resolve the concern in the interest of patient safety.

To read a message from the President of UK NEQAS, click here.

To read the full statement from the RCPath click here. 

UK NEQAS BTLP no longer sending paper instructions

Due to environmental concerns, UK NEQAS BTLP will stop sending paper instructions as standard with samples as of 28/04/25. 

We will continue to send exercise instructions if there is an unusual exercise, and we will always send the COSHH information. 

A link to the exercise instructions can be found on the data entry page, and will be on our website by navigating to the link below and replacing  xxxxxx with the exercise code (e.g. 25E4).

https://www.ukneqash.org/downloads/xxxxxxInstructions.pdf

UK NEQAS IVDR UPDATE

The European Union In Vitro Diagnostics Regulation [Regulation (EU) 2017/746 (EU IVDR)] was implemented on the 26th of May 2022.  A statement of the application of the IVDR to external quality assessment (EQA) services can be found here.